Bai. Ling L; Qiu. Xiaojuan X; Ding. Xinai X; Bai. Xiaoyan X; Huang. Wan W; Yang. Likun L; Shi. Xiaoy...
In a hospital study of 86 patients with septic shock, adding the immune‑boosting peptide thymosin‑alpha‑1 to a blood‑cleansing treatment helped patients recover faster, showed better immune and heart markers, and shortened ICU stays, but it didn’t change overall survival rates. This was done in an emergency setting with specialized equipment, not something you can do at home.
Huang. Run R; Liang. Jiayu J; Luo. Chuang C; Yang. Jiali J; Chen. Huan H; Xie. Xiang X
In mice, daily injections of a sugar called D‑galactose shrink the thymus, mess up its structure, lower the number of important immune cells, and drop the blood level of the peptide thymosin‑α1, especially after 12 weeks. This shows the model can mimic age‑related thymus decline, but it doesn’t give a direct way to boost thymus health in people.
The study looked at how thymosin‑alpha‑1 changes gene activity in bone‑marrow stem cells from kids with a blood disorder, showing it can lower a inflammation‑related gene (TLR9) and raise an immune‑regulating gene (IDO) in lab dishes, but it doesn’t test any real‑world dosing or health benefits for healthy people.
Htain. W W WW; Leong. S K SK; Yuen. R R; Ling. E A EA
In newborn mice, giving thymosin‑alpha‑1 reduced the number of a certain type of brain immune cell (amoeboid microglia) and raised cortisol levels in the blood. Some of the remaining cells changed shape to look more like normal, branching microglia.
Fedorov. T V TV; Korobov. V I VI; Nazarov. V G VG; Smolkina. A E AE; Shmelev. V A VA
Scientists figured out a lab way to pull out a hybrid protein that includes thymosin‑alpha‑1 from bacteria, cleaning it up so it’s pure and active against mouse cancer cells, but the process needs fancy equipment and chemicals, so it isn’t something you can easily do at home or use to guide personal dosing.
Hou. Fang F; Huang. Jian-Ming JM; Zhang. Rong R; Li. Lan L; Li. Ge G
A lab study showed that the peptide thymosin‑alpha‑1 can change signaling in bone‑marrow stem cells from children with aplastic anemia, making those cells better at suppressing T‑cell activity, but this was done in cell cultures, not in people, so it isn’t a ready‑to‑use protocol for healthy individuals.
Alenzi. F Q FQ; Alenazi. F A FA; Al-Kaabi. Y Y; Salem. M L ML
The study tested thymosin‑alpha‑1, IGF‑1, ATRA and several interleukins on mouse CD8+ T cells in a dish. Thymosin‑alpha‑1 didn’t improve the cells’ activation or survival, while IL‑12 and IGF‑1 helped keep a homing marker (CD62L) and reduced early cell death. These findings are mostly relevant to lab‑based T‑cell therapies, not everyday supplement use.
Titova. L D LD; Oradovskaia. I V IV; Sharova. N I NI; Iarilin. A A AA
The study looked at people who worked near Chernobyl and found that long‑term exposure was linked to lower levels of the immune‑modulating peptide thymosin‑alpha‑1 and changes in T‑cell numbers, but it doesn’t give any guidance on how to use or dose the peptide for health benefits.
Zółtowska. A A; Stepiński. J J; Kuczkowski. J J; Kamiński. M M; Cynowska. B B...
The study looked at how certain cells around tiny blood vessels might turn into cancer cells and found that a protein called thymosin‑alpha‑1 (TA1) is present in several tumor types, especially in lung cancer structures that look like thymic tissue. The authors suggest that TA1, a thymic growth factor, could help tumors grow, but they do not test any treatments or give dosing advice.
Sinopoli. N T NT; Pesce. A A; Baldassarre. A M AM; Trivers. G E GE; Frati. L L; Rinaldi-Garaci. C C
The study describes a new, fast lab test (microELISA) that can measure tiny amounts of the peptide thymosin‑alpha‑1 in lab-grown thymus tissue and mouse blood. It shows the test works well, but it doesn't tell you how to use the peptide for health or performance.
Moody. T W TW; Fagarasan. M M; Zia. F F; Cesnjaj. M M; Goldstein. A L AL
In simple terms, the study found that the natural peptide thymosin‑alpha‑1 can slow down the growth of human non‑small cell lung cancer cells in lab dishes and in mice, but its smaller pieces don’t work as well.
Auger. C C; Stahli. C C; Fabien. N N; Monier. J C JC
This study looked at where the tiny protein thymosin‑alpha‑1 lives inside mouse thymus cells. Using special antibodies and electron microscopes, the researchers saw it in small pockets inside normal mice, but in larger, denser pockets in mice that develop autoimmune disease. The work is mostly about basic cell biology and doesn’t give direct advice on how to use thymosin‑alpha‑1 for health or performance.
Shmelev. V A VA; Bunina. Z F ZF; Kudriavtseva. T Iu TIu; Zinchenko. E V EV; Boldyreva. E F EF; Korob...
Scientists engineered new hybrid proteins that fuse the immune‑boosting peptide thymosin‑alpha‑1 with tumor necrosis factor, produced them in bacteria, and tested their effects on mouse cells. The work is mostly about lab techniques and cell toxicity, not about how to use thymosin‑alpha‑1 in humans.
Shmelev. V A VA; Khromykh. L M LM; Dudich. E I EI; Sheviakova. L Ia LIa; Gorbatova. E A EA; Galaktio...
The paper tested engineered proteins that fuse thymosin‑alpha‑1 with tumor‑necrosis‑factor (TNF) and measured their effects on cancer cells and immune cells in the lab. The hybrids showed mixed activity – some kept TNF’s cell‑killing power, others lost it, and they also altered immune cell growth. However, the work is purely experimental, uses cell cultures, and doesn’t give any human dosing or practical guidance for using thymosin‑alpha‑1 on its own.
Dugina. T N TN; Strukova. S M SM; Khlgatian. S V SV; Ashmarin. I P IP
The study shows that the natural peptide thymosin‑alpha‑1 can interfere with a specific form of the clot‑forming enzyme thrombin, reducing its ability to clot fibrinogen and altering cell pH responses, but it doesn’t provide any guidance on how to use the peptide for health or performance benefits.
Kuzmenok. O I OI; Beliakov. I M IM; Iarilin. A A AA; Arshinov. V Iu VIu
The study examined how different types of radiation affect the level of thymosin‑alpha‑1, a peptide involved in immune function, in mice. Both whole‑body and targeted thymus radiation changed blood levels, but in opposite ways, and low‑dose radiation (1 Gy) boosted thymosin release from cultured thymus cells while higher doses suppressed it. Certain radiation doses also triggered auto‑antibodies against thymus cells.
Manrow. R E RE; Sburlati. A R AR; Hanover. J A JA; Berger. S L SL
The study shows that prothymosin alpha, the larger protein that contains thymosin‑alpha‑1, lives inside the cell nucleus rather than being secreted, and its nuclear entry is driven by a specific tail‑end sequence, not the thymosin‑alpha‑1 part.
Medeiros. L J LJ; Bhagat. S K SK; Naylor. P P; Fowler. D D; Jaffe. E S ES; Stetler-Stevenson. M M
This case report describes a patient with a malignant thymus tumor who later showed a high number of normal T‑cells in the blood and unusually high levels of the hormone thymosin‑alpha‑1, while another related hormone was low. The researchers think the extra T‑cells aren’t a second cancer but may be due to an immune imbalance caused by the tumor.
The abstract says most drugs for chronic hepatitis B don’t work well, and thymosin‑alpha‑1 is still being tested in phase III trials with no results yet, so there’s nothing concrete you can apply right now.
Weller. F E FE; Mutchnick. M G MG; Goldstein. A L AL; Naylor. P H PH
The paper describes a lab test that can accurately measure the amount of thymosin beta‑4 in human blood, showing normal adult levels between 3 and 82 ng/ml and lower levels in newborns, but it doesn’t give any advice on using thymosin‑alpha‑1 or how to boost health with these peptides.